Navigation Links
Collegium Pharmaceutical Announces Relocation to Massachusetts
Date:1/17/2013

CANTON, Mass., Jan. 17, 2013 /PRNewswire/ -- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company focused on the development of innovative treatments for chronic pain, today announced the relocation of its corporate offices and laboratory facilities to Canton, Massachusetts from Cumberland, Rhode Island.

The Company's lead development program is Oxycodone DETERx® (COL-003), a tamper-resistant, extended-release oxycodone product utilizing its proprietary DETERx® technology. The Oxycodone DETERx® formulation was specifically designed to provide and preserve extended release of the active ingredient following the most common methods of product tampering employed by drug abusers (e.g., crushing, chewing, heating for IV injection, etc.). The product is currently in the final stage of clinical development and has been designated Fast Track Status by the FDA due to its potential to address the problem of prescription drug abuse, a major public health issue in the U.S.

Extended-release formulations of opioids (e.g., OxyContin®) are known to be attractive targets for non-medical use since they contain large doses of drug. Crushing these dosage forms can defeat the extended-release properties and result in immediate availability of the opioid, also known as "dose dumping." Crushed formulations are commonly self-administered by abusers orally, intranasally or by IV injection, resulting in a "high." Although marketed formulations carry labels warning against crushing and breaking, there are reports of legitimate pain patients crushing tablets to facilitate swallowing, a practice that significantly increases their risk of serious adverse events.

"We are pleased to have completed our relocation to Massachusetts. The new analytical and development labs will facilitate the completion
'/>"/>

SOURCE Collegium Pharmaceutical, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Collegium Pharmaceutical to Present at Piper Jaffrays 24th Annual Healthcare Conference
2. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
3. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
4. Pharmaceutical Industry Service Company Awarded The UKs Most Prestigious Business Accolade in Recognition of Outstanding Achievement in International Trade
5. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
6. Simcere Pharmaceutical Group to Announce First Quarter 2012 Financial Results on Wednesday, May 9, 2012
7. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
8. Thomson Reuters Launches New Mobile Oncology Decision Support Solution for R&D Pharmaceutical Leaders
9. Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company
10. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
11. Icahn Issues Statement Regarding Amylin Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... DIEGO , Feb. 26, 2015  Tandem Diabetes ... device company and manufacturer of the t:slim® and t:flex™ ... public offering of 5,250,000 shares of its common stock ... share.  The net proceeds to Tandem from this offering ... discounts and commissions and other estimated offering expenses payable ...
(Date:2/26/2015)... SOUTH BEND, Ind. , Feb. 26, 2015 /PRNewswire/ ... to announce an agreement with Bank of America (NYSE: ... for consumers nationwide to receive financing of the revolutionary ... accessible vehicle, designed from the ground up to provide ... users. Approved applicants can use their loan to purchase ...
(Date:2/26/2015)... DALLAS , February 26, 2015 ... EU Outlook 2015: First -In- Class Innovations and ... Business for Large Cap Pharmaceutical Companies research report ... According to this Global Pharma US ... divested as productivity measurements, divestment of non-core assets ...
Breaking Medicine Technology:Tandem Diabetes Care Announces Pricing of Underwritten Public Offering of Common Stock 2Tandem Diabetes Care Announces Pricing of Underwritten Public Offering of Common Stock 3Mobility Ventures and Bank of America Announce New Agreement to Simplify Retail Consumer Financing for MV-1 Universally Accessible Vehicle 2Mobility Ventures and Bank of America Announce New Agreement to Simplify Retail Consumer Financing for MV-1 Universally Accessible Vehicle 3Global Pharma U.S. and EU Outlook 2015 Market Research Report 2Global Pharma U.S. and EU Outlook 2015 Market Research Report 3Global Pharma U.S. and EU Outlook 2015 Market Research Report 4
(Date:2/27/2015)... 2015 Cocaine is an extreme stimulant, ... depression and hostility. In a joint effort between Australian ... of cocaine, may soon rejoice in what has been ... addictive biological response of cocaine, according to 7 ... researchers discovered that the brain is continually communicating with ...
(Date:2/27/2015)... 27, 2015 With support from Google, the ... at MoMath, a new collaboration offering Title I schools in ... museum in North America on ten days over the next ... 6-8 from seven schools in the Bronx and Queens will ... , MoMath strives to fulfill the incredible demand for hands-on ...
(Date:2/27/2015)... February 27, 2015 Burien Nursing ... American Health Care, Inc. with the Facility of ... in four key areas: Outstanding quality of care / ... Administrator Lynda Baldwin was invited to attend the awards ... 2015. “I am delighted to receive this award on ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 The ... applications for its next class of Fellows — one ... of radiology business management. , Since 2009, the ... contributions made by RBMA members to the Association and ... prestigious recognition because each Fellow candidate must meet a ...
(Date:2/27/2015)... 27, 2015 The report “Polycystic ... comprehensive information on the therapeutic development for polycystic ... in which a woman's hormones are out of ... among teenage girls and young women. The cause ... strengthens R&D pipelines by identifying new targets and ...
Breaking Medicine News(10 mins):Health News:A New Study May Have an Answer to Treating Cocaine Addiction 2Health News:A New Study May Have an Answer to Treating Cocaine Addiction 3Health News:National Museum of Mathematics and Google Collaborate to Offer Cost-Free Field Trip Days for Title I Schools in NYC 2Health News:National Museum of Mathematics and Google Collaborate to Offer Cost-Free Field Trip Days for Title I Schools in NYC 3Health News:Burien Nursing and Rehabilitation Center Receives Top Honors with Facility of the Year Award 2Health News:Burien Nursing and Rehabilitation Center Receives Top Honors with Facility of the Year Award 3Health News:RBMA Issues Call for Fellowship Applicants 2Health News:Polycystic Ovarian Syndrome Therapeutics Pipeline Market H1 2015 Review Report Now Available at RnRMarketResearch.com 2Health News:Polycystic Ovarian Syndrome Therapeutics Pipeline Market H1 2015 Review Report Now Available at RnRMarketResearch.com 3Health News:Polycystic Ovarian Syndrome Therapeutics Pipeline Market H1 2015 Review Report Now Available at RnRMarketResearch.com 4
... Sydney Brenner, H. Robert Howvitz and John. E. Sulston ... or medicine. The prize has been awarded by the ... discoveries concerning genetic regulation// of organ development and programmed ... 1960’s, that fundamental questions regarding cell differentiation and organ ...
... that cloned animals tend to harbor genetic defects that ... the rational that reproductive cloning of humans should be ... be used safely for therapeutic cloning techniques, such as ... Parkinson's to diabetes. Cloned animals have major ...
... was observed that giving most heart attack patients an ... hospital could dramatically improve their chances of survival. The ... attacks with the extra fuel reduced the risk of ... only for patients whose hearts had not suffered substantial ...
... to a new study, stuttering could be caused by ... brain that triggers nerve disconnection in the regions controlling ... report chronic stuttering seems to be the result of ... hemisphere, the area responsible for speech. To demonstrate this, ...
... new study justifies that children with sleep-disordered breathing ... the study shows a tremendous improvement in behavior ... percent and 6 percent of preschool and school-aged ... upper airway obstruction. This condition is often associated ...
... researchers have identified a gene that causes benign moles on ... treat more effectively patients with early stages of melanoma. A ... Hopkins University, found a gene known as Id1 that causes ... suppressor gene that ordinarily keeps precancerous moles from progressing to ...
Cached Medicine News:Health News:Nobel Prize for Medicine 2Health News:Genetic failure in cloned animals 2Health News:Glucose may support in Cardiac Arrest 2Health News:Brain defect may play role in stammering 2Health News:Tonsillectomy improves quality of life 2Health News:Moles become cancerous due to genes 2